Date published: 2026-5-9

1-800-457-3801

SCBT Portrait Logo
Seach Input

BF-1 Inhibitors

BF-1 inhibitors belong to a distinctive chemical class characterized by their ability to selectively target and modulate the activity of BF-1, a specific protein or enzyme within biological systems. The nomenclature "BF-1" designates a particular molecular target, and inhibitors within this class are engineered to interact with and alter the function of BF-1. These compounds typically exhibit a unique structural framework, featuring specific functional groups and motifs that enable binding to the active site or allosteric regions of BF-1. The design and synthesis of BF-1 inhibitors often involve a combination of medicinal chemistry, structural biology, and computational methods to optimize molecular interactions and enhance binding affinity.

The physiological role of BF-1, the target of these inhibitors, varies across different organisms and biological contexts. BF-1 may play a crucial role in cellular signaling pathways, enzymatic processes, or regulatory mechanisms. By selectively inhibiting BF-1, these compounds can modulate the associated biochemical pathways, influencing cellular functions and responses. The development of BF-1 inhibitors represents a significant area of research in chemical biology and drug discovery, as scientists aim to unravel the intricate details of BF-1's biological functions and explore the potential implications of inhibiting its activity. The exploration of BF-1 inhibitors extends beyond understanding basic biological mechanisms, contributing to the broader field of chemical biology and paving the way for the development of novel tools for investigating cellular processes at the molecular level.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

KT 5720

108068-98-0sc-3538
sc-3538A
sc-3538B
50 µg
100 µg
500 µg
$138.00
$220.00
$972.00
47
(2)

Selectively inhibits PKA by binding to the ATP site, reducing its enzymatic activity.

Rp-cAMPS

151837-09-1sc-24010
1 mg
$203.00
37
(1)

Acts as a PKA inhibitor by mimicking the natural substrate cAMP but is unable to activate the kinase.